DOI: http://dx.doi.org/10.18203/2349-3933.ijam20170122

Profile of gestational dyspnoea with focus on peripartum cardiomyopathy

Meenu M. Tergestina, Legha R.

Abstract


Background: Peripartum cardiomyopathy (PPCM) is even today an incompletely understood and rare disease affecting pregnant women. There have been few studies from south India, especially Kerala on PPCM.

Methods: Women who were referred from Department of Obstetrics and Gynecology from May 2010 to April 2016 for evaluation of dyspnoea during pregnancy or within 5 months of delivery were included in the study. They were screened and women with history suggestive of heart failure during peripartum period were evaluated in detail and followed up.

Results: 8760 pregnant and peripartum women presented with dyspnoea out of which 20 patients were diagnosed with PPCM. The incidence of PPCM was 1 per 2190 pregnancies. The mean left ventricular end-diastolic dimension was 58±9 mm, the mean end-systolic dimension 45±6 mm and mean left ventricular ejection fraction (LV EF) 31.45±3.73%  at diagnosis. Major adverse events (MAE) occurred in 4 patients. Low baseline ejection fraction (LV EF < 30%) significantly correlated with greater incidence of adverse events.

Conclusions: The majority of pregnancy related dyspnoea is benign. Echocardiography can reliably diagnose potentially life threatening conditions and should be performed early. Echocardiography aids in both diagnosis and prognostication in PPCM. Low ejection fraction at baseline (LVEF < 30%) significantly correlates with greater incidence of major adverse events in patients with PPCM.


Keywords


LV ejection fraction, Peripartum cardiomyopathy, Pregnancy dyspnoea

Full Text:

PDF

References


TC Okeke, CCT Ezenyeaku, LC Ikeako. Peripartum Cardiomyopathy. Annals Med Health Sci Res. 2013;3(3):313-9.

Demakis JG, Rahimtoola SH. Peripartum cardiomyopathy. Circulation. 1971;44:964-8.

Pankaj D. Peripartum cardiomyopathy: a review. J Obst Gyne. 2010;60(1):25-32.

Bhattacharyya A, Basra SS, Sen P, Kar B. Peripartum cardiomyopathy. Texas Heart Institute J. 2012;39(1):8-16.

Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, et al. Pregnancy associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation. 2005;111:2050-5.

Pandit V, Shetty S, Kumar A, Sagir A. Incidence and outcome of peripartum cardiomyopathy from a tertiary hospital in South India. Tropical Doctor. 2009;39(3):168-9.

Suri V, Aggarwal N, Kalpdev A, Chopra S, Sikka P, Vijayvergia R. Pregnancy with dilated and peripartum cardiomyopathy: maternal and fetal outcome. Arch Gynecol Obst. 2013;02(287):195-9.

Mcnamara D, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G, et al. Clinical outcomes for peripartum cardiomyopathy in North America: results of the ipac study (investigations of pregnancy-associated cardiomyopathy). J Am Coll Cardiol. 2015;66(8):905-14.